000938:SZSEUnisplendour Corporation Limited Analysis
Data as of 2026-06-21 - not real-time
CN¥27.45
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Unisplendour Corp. posted a robust 34.6% revenue growth, yet its profit margin remains thin at just over 2%, and the company carries a very high debt‑to‑equity ratio of 195%. The stock trades at a trailing PE of 37, slightly below the industry average of 38, while the forward PE drops to 19.7, indicating earnings acceleration ahead. Technicals show the price (27.45 CNY) sitting below the 20‑day SMA (27.59) and 50‑day SMA (29.13), but the MACD histogram turned positive, suggesting a nascent bullish momentum. Volatility is elevated at 57% over the past 30 days, though beta is low (≈0.13), implying limited systematic risk. The dividend yield is modest at 0.24% with a low payout ratio of 10%, supporting dividend sustainability despite the heavy leverage. Analyst consensus (5 analysts) rates the stock as a “buy” with a target median price of 33.77 CNY, implying roughly 23% upside.
Given the decreasing volume trend and a support level near 25.03 CNY, short‑term traders should watch for a break above the 20‑day SMA to confirm the bullish signal. Over the medium horizon, the combination of strong top‑line growth, improving forward earnings, and a sizable upside to target prices makes the stock attractive, though the high debt load and thin margins warrant caution. Long‑term prospects hinge on the company’s ability to capitalize on AI and digital transformation demand while managing its leverage and navigating China’s regulatory environment.
Given the decreasing volume trend and a support level near 25.03 CNY, short‑term traders should watch for a break above the 20‑day SMA to confirm the bullish signal. Over the medium horizon, the combination of strong top‑line growth, improving forward earnings, and a sizable upside to target prices makes the stock attractive, though the high debt load and thin margins warrant caution. Long‑term prospects hinge on the company’s ability to capitalize on AI and digital transformation demand while managing its leverage and navigating China’s regulatory environment.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Positive MACD histogram indicating emerging bullish momentum
- Price near support at 25.03 CNY offering downside cushion
- Current price below short‑term moving averages suggesting room for upside
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Revenue growth of 34.6% outpacing peers
- Forward PE of 19.7 implying earnings acceleration
- Analyst target median price of 33.77 CNY (~23% upside)
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- High debt‑to‑equity ratio (195%) raising financial risk
- Exposure to Chinese tech regulatory environment
- Long‑term demand for AI and digital transformation solutions
Key Metrics & Analysis
Financial Health
Revenue Growth34.60%
Profit Margin2.04%
P/E Ratio37.1
ROE15.79%
ROA2.22%
Debt/Equity195.01
P/B Ratio5.1
Op. Cash FlowCN¥1.2B
Free Cash FlowCN¥-2061887360
Industry P/E38.1
Technical Analysis
TrendNeutral
RSI47.3
SupportCN¥25.03
ResistanceCN¥31.82
MA 20CN¥27.59
MA 50CN¥29.13
MA 200CN¥27.08
MACDBullish
VolumeDecreasing
Fear & Greed Index91.46
Valuation
Fair ValueCN¥1.74
Target PriceCN¥33.81
Upside/Downside23.18%
GradeUndervalued
TypeGrowth
Dividend Yield0.24%
Risk Assessment
Beta0.14
Volatility56.99%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.